Porcine Placental Extract Improves the Lipid Profile and Body Weight in a Post-Menopausal Rat Model Without Affecting Reproductive Tissues.

Introduction: What if porcine placental extract (PPE) could combat post-menopausal weight gain and lipid imbalances without the side effects of traditional hormone treatments? The menopause marks a critical shift in women's health, with declining estrogen levels driving increased risks of obesity, metabolic dysfunction, and cardiovascular disease. While hormone replacement therapy remains a common intervention, concerns over its long-term safety have intensified the search for safer alternatives. Objectives: This study aims to explore the metabolic effects of porcine placental extract (PPE) by using an ovariectomized (OVX) rat model to mimic the hormonal landscape of the menopause. Methods: Twenty OVX Wistar rats were assigned to either a control group receiving phosphate-buffered saline or a PPE-treated group given intraperitoneal PPE injections for two weeks. Results: Remarkably, the PPE-treated rats showed significantly lower body weights than the controls. Biochemical analysis revealed that the PPE-treated rats had improved lipid profiles, involving lower total cholesterol and triglyceride levels. Histological examinations of the PPE-treated rats showed no adverse changes in the uterus or mammary glands. Conclusions: These results highlight PPE's potential as a non-hormonal, tissue-safe intervention for combating weight gain and lipid imbalances in post-menopausal conditions. By promoting lipolysis without impacting reproductive health or muscle mass, PPE opens the door to new possibilities for managing post-menopausal metabolic health. However, further research is needed to determine its long-term efficacy.